(VIANEWS) - China Petroleum & Chemical (SNP), ProAssurance Corporation (PRA), Inari Medical (NARI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. China Petroleum & Chemical (SNP)
64.5% sales growth and 12.96% return on equity
China Petroleum & Chemical Corporation, an energy and chemical company, engages in oil and gas, and chemical operations in the People's Republic of China.
China Petroleum & Chemical's sales growth this year is expected to be 39.6% and 7% for next year.
Year-on-year quarterly revenue growth grew by 43.1%, now sitting on 2.33T for the twelve trailing months.
Volume
Today's last reported volume for China Petroleum & Chemical is 188843 which is 47.44% above its average volume of 128080.
China Petroleum & Chemical's sales growth for the next quarter is 64.5%. The company's growth estimates for the current quarter and the next is 60.6% and 158%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.96%.
Volatility
China Petroleum & Chemical's last day, last week, and last month's current intraday variation average was 0.02%, 0.49%, and 0.97%, respectively.
China Petroleum & Chemical's highest amplitude of average volatility was 0.59% (day), 0.61% (last week), and 1.11% (last month), respectively.
China Petroleum & Chemical's Stock Yearly Top and Bottom Value
China Petroleum & Chemical's stock is valued at $0.00 at 15:22 EST, below its 52-week low of $43.18.
China Petroleum & Chemical's Moving Average
China Petroleum & Chemical's value is under its 50-day moving average of $48.78 and below its 200-day moving average of $50.33.2. ProAssurance Corporation (PRA)
54.7% sales growth and 9.18% return on equity
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States.
ProAssurance Corporation's sales growth this year is expected to be 15.3% and 16.6% for next year.
Year-on-year quarterly revenue growth grew by 36.5%, now sitting on 1.04B for the twelve trailing months.
Volume
Today's last reported volume for ProAssurance Corporation is 199574 which is 1.9% below its average volume of 203445.
ProAssurance Corporation's sales growth for the next quarter is 54.7%. The company's growth estimates for the current quarter and the next is 183.3% and 200%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.18%.
Volatility
ProAssurance Corporation's last day, last week, and last month's current intraday variation average was 0.43%, 2.30%, and 1.90%, respectively.
ProAssurance Corporation's highest amplitude of average volatility was 1.99% (day), 3.88% (last week), and 3.28% (last month), respectively.
ProAssurance Corporation's Stock Yearly Top and Bottom Value
ProAssurance Corporation's stock is valued at $23.00 at 15:22 EST, way below its 52-week high of $29.15 and way higher than its 52-week low of $15.68.
ProAssurance Corporation's Moving Average
ProAssurance Corporation's worth is under its 50-day moving average of $23.67 and below its 200-day moving average of $24.36.3. Inari Medical (NARI)
41.8% sales growth and 12.33% return on equity
Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States.
Inari Medical's sales growth this year is expected to be 81.3% and 25.8% for next year.
Year-on-year quarterly revenue growth grew by 149.9%, now sitting on 208.18M for the twelve trailing months.
Volume
Today's last reported volume for Inari Medical is 245208 which is 44.01% below its average volume of 437983.
Inari Medical's sales growth for the next quarter is 41.8%. The company's growth estimates for the present quarter and the next is a negative 108.3% and negative -69.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.33%.
Volatility
Inari Medical's last day, last week, and last month's current intraday variation average was 1.30%, 3.26%, and 2.37%, respectively.
Inari Medical's highest amplitude of average volatility was 3.94% (day), 4.91% (last week), and 4.43% (last month), respectively.
Inari Medical's Stock Yearly Top and Bottom Value
Inari Medical's stock is valued at $79.00 at 15:22 EST, way below its 52-week high of $127.42 and way higher than its 52-week low of $65.34.
Inari Medical's Moving Average
Inari Medical's worth is below its 50-day moving average of $85.81 and way below its 200-day moving average of $90.83.4. Fortinet (FTNT)
22.4% sales growth and 60% return on equity
Fortinet, Inc. provides broad, integrated, and automated cybersecurity solutions worldwide.
Fortinet's sales growth this year is anticipated to be 24.9% and 17.1% for next year.
Year-on-year quarterly revenue growth grew by 33.2%, now sitting on 3.13B for the twelve trailing months.
Volume
Today's last reported volume for Fortinet is 936547 which is 5.11% below its average volume of 987044.
News about Fortinet(FTNT) today
- According to today's article on CNBC, "The stocks include Palo Alto Networks (PANW), up 2.7%; Airbnb (ABNB), up 2.1%; Fortinet (FTNT), up 3.7%; Lucid Group (LCID), up 5.9%; Zscaler (ZS), up 3.4%; and Datadog (DDOG), up 3.1%."
Fortinet's sales growth for the next quarter is 22.4%. The company's growth estimates for the ongoing quarter and the next is 6.8% and 9.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 60%.
Volatility
Fortinet's last day, last week, and last month's current intraday variation average was 5.12%, 2.39%, and 2.97%, respectively.
Fortinet's highest amplitude of average volatility was 4.43% (day), 3.87% (last week), and 4.54% (last month), respectively.
Fortinet's Stock Yearly Top and Bottom Value
Fortinet's stock is valued at $333.93 at 15:22 EST, under its 52-week high of $355.35 and way higher than its 52-week low of $120.14.
Fortinet's Moving Average
Fortinet's value is higher than its 50-day moving average of $320.88 and way higher than its 200-day moving average of $253.99.Previous days news about Fortinet(FTNT)
- According to Bloomberg Quint on Friday, 10 December, "Palo Alto Networks Inc., which shifted its listing over from the New York Stock Exchange in October in the hopes of being included in the Nasdaq 100, Fortinet Inc., Zscaler Inc. and Datadog Inc. are also potential candidates for the index, according to Moon."